viTToria biotherapeutics
Nicholas Siciliano serves as the Chief Executive Officer at viTToria biotherapeutics since January 2022 and has held multiple roles at Invisible Sentinel, Inc. since December 2006, including Strategic Advisor, Chief Executive Officer, and Chief Operating Officer. Nicholas Siciliano earned a Doctor of Philosophy (Ph.D.) in Immunology and Microbial Pathogenesis from Thomas Jefferson University and a Bachelor of Science (B.S.) in Chemistry and Biochemistry from Villanova University.
This person is not in any offices
viTToria biotherapeutics
Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.